Related Experiment Video
Updated: May 22, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Association of hepatitis C virus infection with risk of ESRD: a population-based study
Fu-Hsiung Su1, Chien-Tien Su, Shih-Ni Chang
1School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taiwan.
Background:
The association between chronic hepatitis C virus (HCV) infection and end-stage renal disease (ESRD) has been widely debated.
Study Design:
National population-based cohort study.
Setting & Participants:
Insurance claims data from the Taiwan National Health Insurance Research Database in 2000-2005.
Predictor:
Chronic HCV infection as defined by the International Classification of Diseases, Ninth Revision, Clinical Modification.
Outcomes:
ESRD as defined by the International Classification of Diseases, Ninth Revision, Clinical Modification.
Results:
We identified 6,291 adults with chronic HCV infection. The control group included 31,455 sex- and age-matched individuals without evidence of chronic hepatitis. The incidence of ESRD was 2.14-fold higher in patients with chronic HCV infection (HR, 1.53; 95% CI, 1.17-2.01; P = 0.002) than in patients without HCV infection. Age stratification analysis showed that patients aged 50-59 years with chronic HCV infection (HR, 7.77; 95% CI, 4.23-14.3; P < 0.001) had the highest risk of developing ESRD relative to patients aged 20-49 years without chronic HCV infection (interaction P < 0.001).
Limitations:
Lack of clinical data.
Conclusions:
Patients with chronic HCV infection are at greater risk of developing ESRD than individuals without chronic HCV infection. In addition, the risk of developing ESRD is highest in younger patients with HCV infection. Early renal screening programs should be initiated for this high-risk group of young individuals with chronic HCV infection.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test